Paradoxical hypersecretion of growth hormone in patients with endometrial atypical hyperplasia and carcinoma: Effect of hysterectomy

Daniel Ayalon*, M. Reuben Peyser, Rodica Limor, Joseph B. Lessing, Roma Ravid

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Paradoxical hypersecretion of human growth hormone (HGH) followed a glucose load in patients with endometrial cancer and atypical hyperplasia of the endometrium. All patients had normal fasting plasma glucose and serum HGH concentrations with a normal glucose tolerance curve. Their urinary estrogen concentrations were within the normal postmenopausal range. 6 months after abdominal total hysterectomy and bilateral oophorectomy, the glucose load was repeated. Following surgery all patients showed a normal suppression of HGH secretion during the hyperglycemic period. These findings suggest the existence of a HGH-releasing factor in the neoplastic and preneoplastic endometrial tissue. This factor might be related to the abnormal HGH responses observed.

Original languageEnglish
Pages (from-to)9-16
Number of pages8
JournalGynecologic and Obstetric Investigation
Volume13
Issue number1
DOIs
StatePublished - 1982

Keywords

  • Atypical hyperplasia
  • Carcinoma
  • Growth hormone
  • Hysterectomy
  • Paradoxical hypersecretion

Fingerprint

Dive into the research topics of 'Paradoxical hypersecretion of growth hormone in patients with endometrial atypical hyperplasia and carcinoma: Effect of hysterectomy'. Together they form a unique fingerprint.

Cite this